MicroPort Scientific : First Firehawk® Implantation in East Europe Completed

Bucharest, Romania - The first implantation of Firehawk Rapamycin Target Eluting Coronary Stent System ('Firehawk') in East Europe was recently successfully completed in Emergency Institute for Cardiovascular Diseases 'Prof. C. C. Iliescu' in Bucharest, the capital city of Romania. Firehawk is a target-eluting stent in-house developed by Shanghai MicroPort Medical (Group) Co ('MicroPort').

The patient is a 48 year-old male with acute myocardial infarction. Professor Adrian Bucsa successfully implanted a Firehawk stent of 2.75/38 mm in a mid-LAD (left anterior descending coronary artery) of the patient, together with Dr. Marin Postu and Dr. Lucian Zarma. There were no dissections at the stent edges and post-dilation with a 3.0 balloon was easily done. Professor Adrian Bucsa commented that Firehawk was easily delivered in treating long lesion with good expansion and quick deflation of the balloon, and overall the experience was good in an acute situation.

In the past decade, percutaneous coronary intervention ('PCI') is experiencing rapid development in Romania, with PCI cases increasing year by year from approximately 5,000 cases in 2005 to 15,000 cases in 2014. The successful completion of the first implantation of Firehawk in East Europe signifies the official entry of the stent in the Romania market and even the East Europe market, to provide ideal treatment solutions to local patients.

About MicroPort

MicroPort Scientific Corporation (the 'Group') is a leading medical device company with business focusing on innovating, manufacturing, and marketing high-quality and high-end medical devices globally. With a diverse portfolio of products now being used at an average rate of one for every 15 seconds in thousands of major hospitals around the world, the Group maintains world-wide operations in a broad range of business segments including Cardiovascular, Orthopedic, Electrophysiological, Endovascular, Neurovascular, Surgical, Diabetes Care and Endocrinal Management, and others. MicroPort is dedicated to becoming a patient oriented global enterprise improve and reshape patient lives through application of innovative science and technology.

For more information, please refer to: www.microport.com

Forward-Looking Statements

Some information contained on this website contains forward-looking statements. These forward-looking statements include, without limitation, those regarding our future financial position, our strategy, plans, objectives, goals and targets, future developments in the markets where we participate or are seeking to participate, and any statements preceded by, followed by or that include the words 'believe', 'intend', 'expect', anticipate', 'project', 'estimate', 'predict', 'is confident', 'has confidence' and similar expressions are also intended to identify forward-looking statements. Such statements are based upon the current beliefs and expectations of MicroPort's management and are subject to significant risks and uncertainties. MicroPort Scientific Corporation undertakes no obligation to update any of the statements. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and other factors that could cause actual future results to differ materially from current expectations include, but are not limited to, general industry and economic conditions, PRC governmental policies and regulations relating to the medical device manufacturing industry, competition in the medical device manufacturing industry, our ability to develop new products and stay abreast of market trends and technological advances, our goals and strategies, our ability to execute strategic acquisitions of, investments in or alliances with other companies and businesses, fluctuations in general economic and business conditions in China.

This document is for information purposes only and does not constitute or form part of any offer or invitation to sell or the solicitation of an offer or invitation to purchase or subscribe for any securities of MicroPort Scientific Corporation, and no part of it shall form the basis of, or be relied upon in connection with, any agreement, arrangement, contract, commitment or investment decision in relation thereto whatsoever.

All rights reserved.
Copyright © 2016 MicroPort Scientific Corporation